JP2024517740A5 - - Google Patents
Info
- Publication number
- JP2024517740A5 JP2024517740A5 JP2023566500A JP2023566500A JP2024517740A5 JP 2024517740 A5 JP2024517740 A5 JP 2024517740A5 JP 2023566500 A JP2023566500 A JP 2023566500A JP 2023566500 A JP2023566500 A JP 2023566500A JP 2024517740 A5 JP2024517740 A5 JP 2024517740A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE2150555-7 | 2021-04-30 | ||
| SE2150555 | 2021-04-30 | ||
| SE2130172-6 | 2021-06-22 | ||
| SE2130172 | 2021-06-22 | ||
| SE2230036-2 | 2022-02-04 | ||
| SE2230036 | 2022-02-04 | ||
| PCT/EP2022/061628 WO2022229458A1 (en) | 2021-04-30 | 2022-04-29 | Substituted hydantoin compounds, methods for preparation thereof and use thereof in the treatment and/or prevention of a corona virus disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024517740A JP2024517740A (ja) | 2024-04-23 |
| JP2024517740A5 true JP2024517740A5 (https=) | 2025-04-02 |
| JPWO2022229458A5 JPWO2022229458A5 (https=) | 2025-04-02 |
Family
ID=81653697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566500A Pending JP2024517740A (ja) | 2021-04-30 | 2022-04-29 | 置換ヒダントイン化合物、その調製方法、並びにコロナウイルス疾患の治療及び／又は予防におけるその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240383890A2 (https=) |
| EP (1) | EP4329883A1 (https=) |
| JP (1) | JP2024517740A (https=) |
| WO (1) | WO2022229458A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024017178A1 (en) * | 2022-07-18 | 2024-01-25 | Avitar Biosciences, Inc. | Substituted hydantoin compounds, pharmaceutical compositions, and therapeutic applications |
| CN115894443B (zh) * | 2022-11-17 | 2024-03-29 | 上海市重大传染病和生物安全研究院 | 一种化合物艾奎斯韦及其应用 |
| WO2025196284A1 (en) | 2024-03-22 | 2025-09-25 | Carlsson Jens | Substituted hydantoin compounds, methods for preparation thereof and use thereof in the treatment and/or prevention of a coronavirus disease |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080066949A (ko) * | 2005-10-11 | 2008-07-17 | 인터뮨, 인크. | 바이러스 복제 억제제 |
| WO2017047146A1 (ja) | 2015-09-17 | 2017-03-23 | オリンパス株式会社 | 内視鏡用処置具 |
| US11572370B2 (en) * | 2018-01-08 | 2023-02-07 | Biohaven Therapeutics Ltd. | CD16A binding agents and uses thereof |
-
2022
- 2022-04-29 US US18/556,116 patent/US20240383890A2/en active Pending
- 2022-04-29 WO PCT/EP2022/061628 patent/WO2022229458A1/en not_active Ceased
- 2022-04-29 JP JP2023566500A patent/JP2024517740A/ja active Pending
- 2022-04-29 EP EP22723459.8A patent/EP4329883A1/en active Pending